Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Becton Dickinson & Co.

Complete the spin-off of the Diabetes Care business

Delivered by the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
6 May 2021
Due
30 Jun 2022
Delivered
1 Apr 2022
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“The transaction is also expected to be completed in the first half of calendar year 2022”
  • SourceBecton Dickinson Form 8-K press release, 2021-05-06
  • FilingSEC filing index
  • Deadline as statedfirst half of calendar year 2022
  • Deadline used30 Jun 2022, the last day of the stated period
  • TypeTransaction
  • Permanent referenceKI-C-2021-BDX-005314
    Cite as https://keptindex.org/c/KI-C-2021-BDX-005314/ — this address never changes.

What we found

Evidence strength A What the grades mean

BD completed the spin-off of its Diabetes Care business as Embecta Corp. on April 1, 2022, within the first half of 2022 deadline.

  • A
    Becton Dickinson 10-Q filed 2022-08-04 Regulatory filing · published 4 Aug 2022 · retrieved 10 Oct 2026 · kept permanently by the SEC · fingerprint 79094c3b1758
    “On April 1, 2022, the Company completed the spin-off of its Diabetes Care business as a separate publicly traded company named Embecta Corp. (“Embecta”)” ✓ confirmed on the page
  • A
    Becton Dickinson 10-K filed 2022-11-22 Regulatory filing · published 22 Nov 2022 · retrieved 10 Oct 2026 · kept permanently by the SEC · fingerprint 972f159e4247
    “On April 1, 2022, BD completed the separation and distribution of Embecta, formerly BD's Diabetes Care business, into a separate, publicly-traded company.” ✓ confirmed on the page

Market reaction: the shares moved +4.9% against the S&P 500 over the three sessions around the disclosure (3 Aug 2022 to 8 Aug 2022). What this measures

Checked 10 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Separation
Indicative materiality
Transformational rules
Action
Complete
Deliverable
Diabetes Care business spinoff
Language
Expected (“expects”, “plans”)
In the company’s control
Medium
Specificity
High
Conditional
Yes: final approval from the BD Board of Directors; regulatory approvals; effectiveness of a Form 10 registration statement
Depends on
Regulatory, Government

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you Becton Dickinson? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-BDX-005314 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.